August 24, 2011

Par Pharmaceutical Cos. will acquire Anchen Pharmaceuticals for $410 million, Par said Wednesday.

July 28, 2011

The president and CEO of Sanofi's U.S. operations is stepping into a newly created role at the drug maker.

July 26, 2011

Watson Pharmaceuticals had sales of $1.1 billion during second quarter 2011, the generic drug maker said.

June 28, 2011

Generic drug maker Hi-Tech Pharmacal said that it has acquired marketing and distribution rights to pain treatments made by Atley Pharmaceuticals.

June 20, 2011

A panel of Food and Drug Administration experts has recommended approval of an investigational biotech drug made by Regeneron Pharmaceuticals for eye diseases.

June 15, 2011

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.

June 7, 2011

The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.

May 26, 2011

Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.

April 21, 2011

The Food and Drug Administration has approved a diabetes drug made by Lupin Pharmaceuticals, according to published reports.

April 6, 2011

Indian drug maker Lupin and U.S. drug maker Salix Pharmaceuticals announced Wednesday a licensing deal for technology related to a drug for traveler’s diarrhea.

March 21, 2011

The generic drug industry’s main lobby in Washington is hoping to head off cuts to the Food and Drug Administration’s Office of Generic Drugs, which it said could have a “devastating impact” on those who rely on generics.

January 4, 2011

Pfizer will pay Danish biotech company Santaris Pharma $14 million for access to its development platform for RNA-based therapies, Pfizer said Tuesday.

November 30, 2010

Ranbaxy Pharmaceuticals has received final approval for its generic Alzheimer's drug from the Food and Drug Administration, giving the drug maker 180 days of market exclusivity.

November 14, 2010

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

November 9, 2010

Watson Pharmaceuticals biotech subsidiary Eden Biodesign has signed a manufacturing agreement with Dutch biotech company...

November 2, 2010

Earnings per share for AmerisourceBergen rose nearly 14% during the fourth quarter ended Sept. 30,...

November 2, 2010

The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for...

October 20, 2010

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday....

October 11, 2010

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

September 27, 2010

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 26, 2010

Winc Design is launching its Charlie Banana brand of environmentally friendly cloth diapers and baby...

September 26, 2010

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

August 9, 2010

Generic drug maker Watson Pharmaceuticals posted strong sales for second quarter 2010, according to an...